MLXIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.951200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.375800E-01
Normal-vs-Stage2
3.973200E-01
Normal-vs-Stage3
9.583700E-03
Normal-vs-Stage4
1.200170E-01
Stage1-vs-Stage2
4.025400E-01
Stage1-vs-Stage3
1.157790E-01
Stage1-vs-Stage4
4.660800E-01
Stage2-vs-Stage3
1.986760E-01
Stage2-vs-Stage4
8.610400E-01
Stage3-vs-Stage4
6.977700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.071200E-01
Normal-vs-AfricanAmerican
6.746400E-01
Normal-vs-Asian
2.283600E-01
Caucasian-vs-AfricanAmerican
7.214200E-01
Caucasian-vs-Asian
3.159400E-01
AfricanAmerican-vs-Asian
4.227800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.021200E-01
Normal-vs-Female
2.758800E-01
Male-vs-Female
3.303400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.743000E-01
Normal-vs-Age(41-60Yrs)
4.855400E-01
Normal-vs-Age(61-80Yrs)
3.398000E-01
Normal-vs-Age(81-100Yrs)
4.989200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.354200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.695600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.437600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.612410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.729400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.726040E-01
Normal-vs-Daily Drinker
5.539900E-02
Normal-vs-Weekly Drinker
3.081000E-01
Normal-vs-Occasional Drinker
1.549040E-01
Normal-vs-Social Drinker
8.201000E-01
Non Drinker-vs-Daily Drinker
7.318400E-01
Non Drinker-vs-Weekly Drinker
5.783400E-01
Non Drinker-vs-Occasional Drinker
4.553200E-01
Non Drinker-vs-Social Drinker
9.167600E-02
Daily Drinker-vs-Weekly Drinker
3.645200E-01
Daily Drinker-vs-Occasional Drinker
2.172800E-01
Daily Drinker-vs-Social Drinker
8.542200E-02
Weekly Drinker-vs-Occasional Drinker
9.483800E-01
Weekly Drinker-vs-Social Drinker
3.352800E-01
Occasional Drinker-vs-Social Drinker
2.942800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.100000E-01
Normal-vs-Grade 2
7.317900E-02
Normal-vs-Grade 3
8.262200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.936600E-01
Grade 1-vs-Grade 3
9.805600E-01
Grade 1-vs-Grade 4
2.100000E-01
Grade 2-vs-Grade 3
7.099400E-01
Grade 2-vs-Grade 4
7.317900E-02
Grade 3-vs-Grade 4
8.262200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.281000E-01
Normal-vs-NonDiabetic
3.093800E-01
Diabetic-vs-NonDiabetic
4.970800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.971000E-01
Normal-vs-NoPancreatitis
2.648800E-01
Pancreatitis-vs-NoPancreatitis
9.743600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.328000E-01
Normal-vs-N1
3.928400E-01
N0-vs-N1
5.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.095000E-01
Normal-vs-TP53-NonMutant
5.719800E-01
TP53-Mutant-vs-TP53-NonMutant
1.724440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
